<DOC>
	<DOCNO>NCT02894918</DOCNO>
	<brief_summary>This study evaluate whether addition Peginterferon alfa-2a CHB Patients Treated nucleoside analogues ( NAs ) enhance rate HBsAg clearance end treatment . This study Randomized , open-label , multi-center study . The CHB patient NAs treatment achieve HBV DNA &lt; 15 IU/ml、HBeAg &lt; 100 PEIU/ml、HBsAg positive HBsAg &lt; 1500 IU/ml randomize 2 group : Group 1 ( Combination group ) : Maintain NAs treatment add 48-week standard treatment Peginterferon alfa 2a 180µg/week Group 2 ( Mono NA group ) : Maintain NAs treatment 49 week . Note : NAs include : LAM , ADV , ETV , TDF .</brief_summary>
	<brief_title>A Study Evaluate Addition Peginterferon Alfa-2a Chronic Hepatitis B ( CHB ) Patients Treated With NAs</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Male female patient &gt; 18 ≤65 year age ; Diagnosed chronic hepatitis B ( HBsAg ( + ) 6 month nucleos ( ) ide analogue treatment ) Patients achieved HBV DNA &lt; 15 IU/ml、HBeAg &lt; 100 PEIU/ml、HBsAg positive HBsAg &lt; 1500 IU/ml treatment Nucleoside ( acid ) Analogues ( include LAM , ADV , ETV , TDF ) Decompensated liver disease : include ascites , hepatic encephalopathy , esophagogastricvaricosis fissure bleed decompensated complication ; Hypersensitive interferon ( IFN ) active substance , ineligible IFN ; A history immunoregulation drug therapy within 1 year entry include IFN ; Coinfection HAV、HCV、HDV、HEV 、HIV Other chronic liver diseases Alcoholic Liver Disease , Inherited Metabolic Liver Disease , Drug induce Liver Disease nonalcoholic fatty liver , autoimmune disease include autoimmune hepatitis Psoriasis ; Hepatocellular carcinoma ( HCC ) alpha feto protein ( AFP ) level 100ng/ml Hepatic malignant potential Imaging examination AFP level 100 ng/ml 3 month ; A neutrophil count less 1500 per cubic millimeter platelet count le 90,000 per cubic millimeter ; A serum creatinine level 1.5 time upper limit normal range ; With malignant tumor ( exclude cure one ) ; Severe organ dysfunction ; With severe psychiatric condition nervous disease epilepsy , depression , mania , epilepsy , schizophrenia ; Uncontrolled diabetes , hypertension thyroid disease ; Pregnant woman lactate woman patient pregnancy plan willing use contraception study period ; Participate clinical study time ; Patients unsuitable research ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>